PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma

Title
PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma
Authors
Keywords
-
Journal
NEUROLOGY
Volume -, Issue -, Pages 10.1212/WNL.0000000000006283
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2018-09-01
DOI
10.1212/wnl.0000000000006283

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started